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Abstract
Human herpesvirus-6 (HHV-6) exists in latent form either as a nuclear episome or integrated into human chromosomes in
more than 90% of healthy individuals without causing clinical symptoms. Immunosuppression and stress conditions can
reactivate HHV-6 replication, associated with clinical complications and even death. We have previously shown that co-
infection of Chlamydia trachomatis and HHV-6 promotes chlamydial persistence and increases viral uptake in an in vitro cell
culture model. Here we investigated C. trachomatis-induced HHV-6 activation in cell lines and fresh blood samples from
patients having Chromosomally integrated HHV-6 (CiHHV-6). We observed activation of latent HHV-6 DNA replication in
CiHHV-6 cell lines and fresh blood cells without formation of viral particles. Interestingly, we detected HHV-6 DNA in blood
as well as cervical swabs from C. trachomatis-infected women. Low virus titers correlated with high C. trachomatis load and
vice versa, demonstrating a potentially significant interaction of these pathogens in blood cells and in the cervix of infected
patients. Our data suggest a thus far underestimated interference of HHV-6 and C. trachomatis with a likely impact on the
disease outcome as consequence of co-infection.
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Introduction
Human herpes virus 6 (HHV-6) is a ubiquitous pathogen with
more than 90% seroprevalence in healthy adults. HHV-6 is
commonly associated with self-limited childhood illness roseola
infantum, and rarely with more severe syndromes. Chronic viral
replication mostly occurs in salivary glands whereas HHV-6
persists in a latent stage in various tissue types including monocytes
and bone marrow progenitor cells. Latent HHV-6 resides in the
host cell as nuclear episome [1,2] or integrated into telomeric ends
of host cell chromosomes. The later form of latent HHV-6 can be
vertically transmitted in the germ line [3,4,5]. Chromosomal
integration of HHV-6 is described to be the most common form of
latent HHV-6 [3]. After acquiring latency, HHV-6 persists in
a dormant state with minimal viral transcription or translation in
human host cells without any clinical complications. However,
under various physiological conditions, latent HHV-6 is reacti-
vated to form infectious viral particles (for further details see
reviews [6,7,8]). In immune compromised patients, reactivation of
viral activity may lead to severe limbic encephalitis [9]. HHV-6
reactivation has been correlated with relapsing and secondary
progressive multiple sclerosis (MS) [10,11,12,13] and Chronic
Fatigue Syndrome (CFS) [11,14]. Reactivation of latent HHV-6
can also be achieved by treatment with chemical stimulators like
Trichostatin A (TSA), 12-O-tetradecanoyl-phorbol-13-acetate
(TPA), calcium ionophore A23187 and hydrocortisone leading
to viral replication in an extra-chromosomal state, viral gene
transcription and formation of new infectious viral particles
[3,5,15].
The Gram-negative, obligate intracellular bacterium Chlamydia
trachomatis is the leading infectious cause of blindness and the third
most frequent sexually transmitted infection worldwide. Epidemi-
ological studies have connected HHVs and Chlamydia in several
conditions. Herpes simplex virus 2 (HSV-2) is associated with C.
trachomatis in endometritis and acute salpingitis [16]. HHV-6 DNA
is frequently detected in different grades of cervical lesions [17,18].
C. trachomatis infection has also been separately linked to cervical
cancer [19] but it is unclear, whether both these pathogens
contribute to the development of cervical cancer. Chlamydia
pneumoniae, a highly prevalent pathogen with up to 80% serum
antibody positivity in adults, is the cause of pneumonia in humans,
but has also been associated with chronic diseases like atheroscle-
rosis, progressive neurological disorders and lung cancer. In CFS
patients, HHV-6 has been identified together with C. pneumoniae
[20]. Although still controversially discussed, support for a role of
C. pneumoniae and HHV-6 co-infection in the development and
progression of MS has been provided [21,22]. Although C.
trachomatis and C. pneumoniae differ in their tissue tropism, they have
PLOS ONE | www.plosone.org 1 April 2013 | Volume 8 | Issue 4 | e61400
a similar infection physiology. In a previous study, we have shown
that co-infection with HHV-6 influences the development of
infectious progeny of both, C. trachomatis and C. pneumoniae [23].
Moreover, different herpes viruses like herpes simplex virus (HSV)-
1 and HSV-2 and human cytomegalovirus influence chlamydial
infectivity in a similar way [23].
Here, we studied the influence of chlamydial infection on latent
HHV-6 and its activation. Our data show that Chlamydia infection
induces replication of chromosomally integrated HHV-6 in both
immortalized human cells as well as in freshly isolated blood cells.
To get a better insight into such interaction in vivo, we investigated
cervical swabs from patients with C. trachomatis-infection for the
HHV-6 and C. trachomatis load by qPCR. Our data provide
statistically significant correlations supporting an interaction
between HHV-6 and C. trachomatis.
Materials and Methods
Cell Lines, Patients and Samples
For the study of latent CiHHV-6 activation, established
CiHHV-6 cell lines like HSB-ML (a tetraploid T-cell line derived
from HBS-2 cells with 2–5 copies of CiHHV-6), JL-LCL and PL-
LCL (cell lines established from CiHHV-6 individuals with 1–2
copies of HHV-6A per cell) were kindly provided by the HHV-6
foundation, USA (www.hhv-6foundation.org/, www.
bioworldantibodies.com). Fresh blood samples from 5 individuals
with CiHHV-6 were also provided by the HHV-6 foundation,
USA. Viral load was re-verified by qPCR, which confirmed the
CiHHV-6 status of these cells. Cervical swabs and blood samples
were available from 73 female patients attending the outpatient
Sexually Transmitted Infection (STI) clinic of Helsinki University
Central Hospital, Helsinki, Finland. The patients were recruited to
the study because of symptoms suggestive of C. trachomatis
infection, or because notified by an infected partner. Cervical
swabs were collected in 2 different sample buffers. Cervical swabs
collected in Gen-Probe Aptima specimen collection media (Gen-
Probe Inc., USA) were tested for C. trachomatis ribosomal RNA by
Aptima Combo 2 Assay (Gen-Probe). The cervical samples
collected in Copan UTM-RT media (Copan Diagnostics Inc.,
USA) were used for culture, then stored at -80uC and later used for
total DNA extraction and detection of C. trachomatis and HHV-6
viral load. C. trachomatis antibodies were determined by micro-IF
test.
HeLa cells containing latent HHV-6, HSB-2 and Molt-3 cells
[23] were grown in RPMI 1640 media and 5% fetal bovine serum
(FBS) at 37uC and 5% CO2.
Ethics Statement
The CiHHV-6 blood samples were collected under written
informed consent under IRB# CI001-HHV6 approved by The
Essex Institutional Review Board Committee. Informed written
consent was also obtained from all participants of the Chlamy-
Trans Study, and the ethics committee approved the consent
procedure. A study permit was obtained from Helsinki University
Central Hospital, Laboratory Division (HUSLAB). The Ethics
Committee of the Department of Medicine, Hospital District of
Helsinki and Uusimaa evaluated and approved the ChlamyTrans
research plan (Dnro HUS 206/13/03/01/09, 19.08.2009). The
Ethics Committee of the Department of Medicine (in Finnish:
Sisa¨tautien eettinen toimikunta), Hospital District of Helsinki and
Uusimaa is an independent review board/ethics committee.
Peripheral Blood Mononuclear Cell (PBMC) Isolation
Fresh PBMCs were first separated from whole blood using
Histopaq1077 solution (Sigma, St. Louis, MO, USA) according to
manufacturer’s instructions. Briefly, freshly collected blood was
diluted 2 times with PBS and layered carefully onto 1 volume of
Histopaq1077 solution without mixing the solutions. PBMCs were
collected after centrifugation at 6006g for 30 min at room
temperature. Cells were washed 3 times with 25 volumes of PBS
and kept in RPMI 1640 media with 5% fetal bovine serum (FBS)
at 37uC and 5% CO2. Isolated PBMCs were cultured on a plastic
culture dish (NUNC, USA) for 48 h to separate monocytes, which
later differentiate to macrophages. Separated adherent monocytes
were further cultured for 5–7 days in presence of 50 ng/ml of
macrophage colony stimulating factor (M-CSF) (Sigma, USA) to
allow complete differentiation into macrophages. Both the
adherent macrophage fraction and the PBMC fractions were
infected with C. trachomatis separately.
Chlamydia Trachomatis Infection
CiHHV-6 containing cells and PBMCs (both monocyte derived
macrophages and leukocytes) were infected with C. trachomatis at an
MOI of 5 either in an Eppendorf tube or on a culture plate and
were centrifuged for 1 h at 37uC at 12006g as described
previously [23]. Cells were washed 3 times with PBS and grown
in fresh RPMI 1640 media with 5% FBS.
DNA Extraction from Cervical Swabs
Total DNA was extracted from the cervical swabs using
MagNA Pure LC Total Nucleic Acid Isolation Kit (Roche
Diagnostics, Germany) with minor modifications. Briefly, 1 ml of
the cervical swab sample stored in Copan UTM-RT media was
mixed with 100 ml of magnetic beads. To this, 450 ml of lysis/
Binding binding buffer was added together with 150 ml of
Proteinase-K and 1 ml of RNAse A. Samples were mixed
thoroughly and incubated for 5 min at room temperature. Beads
were separated by a magnet and subsequently 850 ml of wash
buffer I was added. Beads were again separated and then washed
Table 1. Detection of Chlamydia and HHV-6 in cervical swab samples and total blood.
C. trachomatis HHV-6
Negative (n =18) Positive (n =55)
HHV-6 positive (only in
cervix)
HHV-6 positive (only in
total blood)
HHV-6 positive (both in
total blood and cervix)
Negative (n = 25) n=7 n=1 n=5 n=12
Positive (n =48) n=11 n=11 n=13 n=13
73 cervical swab and total blood samples were tested by qPCR for Chlamydia and HHV-6.
doi:10.1371/journal.pone.0061400.t001
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Figure 1. Chlamydia trachomatis infection induces CiHHV-6 DNA replication. (A) qPCR analysis of viral DNA in HSB-ML cells after 2 days of C.
trachomatis infection. HSB-ML cells were infected with C. trachomatis (Ctr) for 2 days. In parallel, the same number of HSB-ML cells was cultured in the
presence of 1 mM hydrocortisone or 80 ng/ml of TSA for 2 days. As TSA was dissolved in DMSO, a DMSO control was also included in the study. Data
represent the mean 6 SEM of 5 independent experiments. (B) qPCR analysis of viral DNA in HeLa cells carrying latent HHV-6A after 2 days of C.
trachomatis infection. Cells were infected with C. trachomatis or were treated with TSA or hydrocortisone as mentioned in (A). Data represent the
mean 6 SEM of 5 independent experiments. (C, D, E) qPCR analysis of viral DNA in HSB-ML (C), JL-LCL (D) and PL-LCL (E) cells after 9 days of C.
trachomatis infection. Cells were infected with C. trachomatis at an MOI of 2–5 for 2 days after which cells were washed thoroughly and grown in
presence of fresh media with 1 mg/ml of doxycycline for another 7 days. Total DNA was isolated and used for qPCR assay. Data represent the mean6
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with 450 ml of wash buffer II and then followed by another wash in
450 ml of wash buffer III. Bead bound DNA was eluted in 100 ml
of elution buffer at 70uC. Removal of RNA from the DNA
preparations was confirmed by analyzing random samples with
DNAse treatment and reverse transcription PCR. Amount of
DNA was quantified using NanoDrop 1000 Spectrophotometer
(Thermo Scientific, Germany) and was stored at 220uC until
further analysis.
DNA Extraction From Blood
Total DNA was extracted from whole blood samples using
QIAamp DNA Blood Mini Kit (Qiagen, Germany) following
manufacturer’s protocol.
Preparation of Plasmids for Standard Curve Analysis
HHV-6A (U1102), HHV-6B (Z29) [23], U94 ORF, C.
trachomatis type III secretion chaperon LcrH/SycD, PI15 ORF
were amplified using primer pairs described in Table 1. Amplified
PCR products were agarose gel purified and were cloned into
TOPO pCR 2.1 vector (Life Technologies, Germany). Cloned
DNA vectors were transformed into E. coli DH5a and propagated
to isolate ample amount of vectors for qPCR analysis. Cloned
ORFs were verified by DNA sequencing.
Quantitative Real time PCR (qPCR)
For qPCR, PerfeCTaTM qPCR SuperMix (Quanta Biosciences)
was used and PCR amplifications were done on a StepOnePlusTM
real time PCR platform (Applied Biosciences) using manufac-
turer’s protocol and SYBRH Green chemistry. qPCR reactions
were performed using 100 ng of DNA per sample per well.
Amplified data were analyzed using StepOneTM Software v2.1.
Primer details are provided in table 1.
Statistical Analysis
For categorically scaled measures, results are presented as
numbers and frequencies. In case of metric data, mean, median
and the standard deviation is given unless otherwise stated. To
assess the relationship between two categorical measures, the chi-
square test was used. When comparing a metric measure between
two independent samples the normality assumption was checked
first. If normality was given, the t-test was performed, otherwise
the Wilcoxon test was used. For the comparison of more than two
independent groups the Kruskal-Wallis test was conducted. The
binomial test was done for the comparison of two proportions. All
tests were two-tailed and differences were considered statistically
significant if P,0.05. The software package used was IBM SPSS
for Windows, version 19.0.
Activation of HHV-6
To study HHV-6 reactivation, CiHHV-6 cell lines and fresh
blood samples from individuals with CiHHV-6, were infected with
C. trachomatis serovar L2 at an MOI of 1–5. Chlamydial infection
was monitored by phase contrast microscopy. In parallel, CiHHV-
6 cells were cultured in RPMI medium 1640 supplemented with
10% FCS together with 161026 M hydrocortisone or 80 ng/ml
Trichostatin A (TSA) (Sigma, USA) for 3–5 days, which are known
to induce HHV-6 reactivation. After 2–3 days of infection, cells
were grown in fresh media supplemented with 1 mg/ml of
doxycycline, which allowed Chlamydia infected cells to recover.
As HSB-2 and Molt-3 cells (T-cell derived cells) allows productive
HHV-6 infection, 16104 HSB-2 or Molt-3 cells were added to 106
PBMCs and co-cultured for 10–14 days in order to recover the
reactivated viruses. Reactivation of HHV-6 was monitored by
analysis of cytopathic effects, Gardella gel analysis and detection of
viral genomes by qPCR.
Gardella Gel Analysis
Gardella gel analysis allows the detection of large episomal
DNA as it is formed as a consequence of HHV-6 reactivation. This
method was used to separate episomal HHV-6 DNA from cellular
DNA as described by Gardella et al. [24] with minor modifica-
tions. Briefly, 2.56106 CiHHV-6 cells co-cultured with HSB-2 or
Molt-3 cells were directly lysed inside each well of a vertical
polyacrylamide gel in a sample buffer containing 15% Ficol, 2
Kunitz units of RNAase type1A (Sigma, USA) per ml, and 0.01%
bromophenol blue in TBE buffer and were layered with lysis
buffer containing 5% Ficoll, 1% SDS, 1 mg of pronase (Sigma,
USA) per ml and 0.05% xylene cyanol green. For lysis of isolated
chlamydial elementary bodies (EB), samples were lysed in above
mentioned lysis buffer containing lysozyme (Sigma, USA) at a final
concentration of 7,500 U/ml. Gels were run at 4uC overnight and
then stained in ethidium bromide for visualization of DNA.
Subsequently, gels were used for southern transfer and hybridiza-
tion.
Southern Hybridization
Gardella gels were incubated in 0.125 M HCl for 10 min and
then in DNA denaturation buffer (1.5 M NaCl, 0.5 M NaOH) for
30 min. DNA was transferred to Nylon-XL membrane (Amer-
sham Hybond-XL, GE life sciences) by capillary transfer using
denaturation buffer for transfer. After transfer, membrane was
washed with neutralization buffer (3 M NaCl, 0.3 M Tri-sodium
citrate, 0.5 M Tris, pH 8.0) for 15 min and was subsequently pre-
incubated in hybridization buffer (GE life sciences, USA). After
1 h of pre-incubation, either random primed C. trachomatis probes
(GE life sciences, USA) or end labeled HHV-6 oligo probes (Table
S1) were added to the hybridization buffer and incubated
overnight at 65uC or at 42uC, respectively. Membranes were
washed and exposed overnight to phosphor storage screens
(Fujifilm), which were then scanned by Typhoon 9200 imager
(GE Healthcare). PCR amplified Ctr LcrH/SycD gene product of
136 bp was used for random priming and subsequent as probe.
SEM of three independent experiments. (F) qPCR analysis of viral DNA in freshly isolated blood cells from CiHHV-6 individuals after 5 days of C.
trachomatis infection. Fresh PBMCs were isolated from total blood and were infected with C. trachomatis for 2 days at an MOI of 5 after which cells
were washed thoroughly and grown in presence of fresh media with 1 mg/ml of doxycycline for another 3 days. In parallel, the same numbers of
PBMCs were cultured in presence of 80 ng/ml of TSA for 5 days. Total leukocytes were separated from monocyte-derived macrophages and were
infected with C. trachomatis in parallel. Heat inactivated C. trachomatis (hiCtr) were added to total PBMCs in a separate well and were included as
negative control. Data represent the mean 6 SEM of results from blood samples of 5 different CiHHV-6 individuals. (G) qPCR analysis of viral DNA in
total leukocytes and monocyte-derived macrophages from CiHHV-6 individuals after 5 days of C. trachomatis infection. Total leukocytes were
separated from monocyte-derived macrophages and were infected with C. trachomatis for 2 days at an MOI of 5 after which cells were washed
thoroughly and grown in presence of fresh media with 1 mg/ml of doxycycline for another 3 days. Data represent the mean 6 SEM of three
independent experiments performed at the same time from one CiHHV-6 individual.
doi:10.1371/journal.pone.0061400.g001
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Figure 2. C. trachomatis infection induces formation of extra-chromosomal HHV-6 DNA in CiHHV-6 cell lines and patient blood
samples. (A) C. trachomatis infection induces viral DNA replication in HSB-ML cells. HSB-ML cells were infected with C. trachomatis at an MOI of 2 for
2 days after which cells were washed thoroughly and grown in presence of fresh media with 1 mg/ml of doxycycline for 35 days. Total DNA was
isolated at 3 different time intervals and used for qPCR assay. Data represent the mean 6 SEM of 3 independent experiments. (B) Southern
hybridization of C. trachomatis-infected HSB-ML cells shows detectable amount of extra-chromosomal HHV-6 after 35 days of infection. Total DNA
from non-infected (NI) and 35 days post infected (dpi) HSB-ML cells were run on 1% agarose gel and were subsequently used for southern transfer
and hybridization. HHV-6 specific band is marked by dark arrowhead. (C) Ethidium bromide (EtBr) stained agarose gel showing full-length HHV-6 DNA
in total PBMCs of a CiHHV-6 individual after 16 days of Chlamydia treatment. Fl, full-length. (D) Same gel as in (C) was processed for neutral-neutral
2D DNA electrophoresis and subsequent hybridization with a HHV6 probe and then with C. trachomatis probe. Migration rate of full-length HHV-6
DNA from C. trachomatis-infected cells is different from that of mock infected cells. Ori, the position of the origin of the second-dimension gel
Chlamydia Induces HHV-6 DNA Replication
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Neutral–neutral 2D DNA Electrophoresis
Separation of DNA in neutral–neutral 2D gels was performed as
previously described [25]. Briefly, DNA was first separated on
0.4% agarose at low voltage in 0.56TBE, and the gel was stained
with 0.3 mg/ml ethidium bromide. The lane was cut and placed
on a clean gel support at 90u to the direction of the first
electrophoresis. The positions of the size markers for the first-dimension gel electrophoresis are shown at the top. (E) Gardella gel analysis and
subsequent southern hybridization showing extra-chromosomal HHV-6 DNA after C. trachomatis infection. HSB-ML and JL-LCL cells were infected
with C. trachomatis (MOI 5) for 2 days after which cells were washed thoroughly and grown in presence of fresh media with 1 mg/ml of doxycycline
for another 7 days. Fresh HSB-2 cells were added to these cells and were co-cultured for another 2 weeks. 2.56106 of these cells were loaded directly
onto a Gardella gel and subsequently stained with ethidium bromide and afterwards transferred to a nylon membrane. HSB-2, HHV-6-infected HSB-2
for productive virus infection (HSB-2+HHV-6), C. trachomatis elementary bodies (Ctr EB) and C. trachomatis-infected HSB-ML cells, which were
subsequently not co-cultured with HSB-2 cells (HSB-ML+Ctr) were loaded as controls. Nylon membrane was hybridized first with a HHV-6-specific
probe and subsequently stripped and used again for hybridization with C. trachomatis-specific probe. Extra-chromosomal linear HHV-6 DNA is
marked with *and possible nicked circular viral DNA is marked with a rectangle. Chlamydial DNA did not run in the gel due to the size of genomic
DNA and hence C. trachomatis-specific hybridization was observed only in the wells of lane 4 and 5. A clear band (probably the chlamydial plasmid) in
lane 3, which was observed after ethidium bromide staining was not detected by C. trachomatis-specific probe. Instead some additional bands were
detected in lane 4 with C. trachomatis-specific probes. (F) Transmission electron microscopy pictures showing appearance of particle like condensed
DNA structures (marked by black arrowhead) in CiHHV-6 cell nuclei after Chlamydia infection.
doi:10.1371/journal.pone.0061400.g002
Figure 3. Quantitative real time PCR assay to detect HHV-6 and chlamydial load in cervical swabs and total blood samples. (A–C)
Standard curves for HHV-6 and C. trachomatis quantification. Ten fold serial dilutions of U94 HHV-6A (A), C. trachomatis (B) and PI15 (C) plasmids
were tested in triplicates in qPCR reaction. Mean Ct values were plotted against the copy numbers. Correlation coefficients and slope values are
mentioned in each figure. (D) Scatter plot showing quantitative distribution of HHV-6 and C. trachomatis in cervical swabs of patients (n = 65) with
suspected C. trachomatis infection as determined by real-time qPCR assay. Samples with no detectable HHV-6 and C. trachomatis are not included.
Samples with HHV-6 DNA below detection limit (5 copies/103 cells) were arbitrarily specified as 4 copies/103 cells. Similarly, samples with less than
100 copies/103 cells were arbitrarily specified as 50 copies/103 cells. Sensitivity of PCR was marked as detection limits.
doi:10.1371/journal.pone.0061400.g003
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electrophoresis, cast with 1.1% agarose containing 0.3 mg/ml
ethidium bromide and run in 0.56TBE. The first dimension was
run overnight at 1 V/cm, and the second at 4 V/cm for 3.5 h,
both at room temperature. Southern blot analyses were performed
as described above.
Results
C. trachomatis Infection Induces CiHHV-6 DNA
Replication and Formation of Extra-chromosomal HHV-6
DNA
To test the effect of C. trachomatis-infection on latent chromo-
somally integrated HHV-6 (CiHHV-6) DNA replication, we
infected HSB-ML cells carrying 1–2 copies of HHV-6A per cell
with C. trachomatis (MOI 1) (Figure 1A). We also infected cervical
epithelial HeLa cells carrying latent HHV-6A (100 copies of
HHV-6A per 1000 cells) (Figure 1B) [23]. Total DNA extracted at
2 days post infection (dpi) and 9 dpi was used for quantitative PCR
(qPCR) [23] against HHV-6 U94 ORF (Table S1). In parallel, all
the cell lines were treated with hydrocortisone (1 mM) or TSA
(80 ng/ml), which were previously shown to induce latent HHV-6
DNA replication [3]. DMSO solvent controls were included in
separate wells/cultures and all experiments were repeated at least
5 times. We observed increased amount of viral DNA in both cell
types at 2 days after C. trachomatis infection (Figure 1A, 1B).
Hydrocortisone treatment did not induce any HHV-6 replication
in our system. HHV-6 DNA replication induced by C. trachomatis
infection was comparable to that observed upon treatment with
the chemical inducers TSA. The increase in the amount of viral
DNA, however, was not statistically significant because of high
level of variation within the experiments. Interestingly, at 9 dpi the
amount of viral DNA was significantly higher than in unstimulated
cells (p,0.05) (Figure 1C). Similar experiments were carried out
using 2 other CiHHV-6 cell lines (JL-LCL and PL-LCL), and
a 1.8–2.4 fold increase in the amount of viral DNA at 9 dpi was
observed (Figure 1D, 1E).
To test the effect of C. trachomatis on replication of latent HHV-6
in fresh PBMCs, we isolated PBMCs from 5 healthy individuals
having CiHHV-6. The PBMC were either directly infected with C.
trachomatis for 3 days or used for separation of monocytes from total
leukocytes (see Material and Methods), which were further
differentiated into macrophages. Total leukocytes and monocyte-
derived macrophages were then separately infected with C.
trachomatis (MOI 1–5) for 3 days. Heat inactivated C. trachomatis
(hiCtr) was used as a (negative) control. Total DNA was extracted
at 3 dpi and analyzed by qPCR. We observed a minor increase
(1.3-fold) in the amount of viral DNA in the presence of TSA
whereas a 1.7-fold increase was observed when total PBMCs were
infected with C. trachomatis (Figure 1F). In order to check cell type
specificity for C. trachomatis infection and subsequent viral
activation, we analyzed the amount of viral DNA in total
leukocytes as well as in monocyte-derived macrophages. We
observed up to 3.6-fold increase in the amount of viral DNA in
monocyte-derived macrophages whereas only a 1.6-fold increase
Table 2. HHV-6 and chlamydial load in the Chlamydia negative control group.
Sample Ctr IgG Ctr IgM Ctr IgA NAAT results
Blood virus
load/103 cells
Cervical virus
load/103 cells
Cervical Ctr
load/103 cells
1 CT103 ,32 ND ND NEG 7.012237438 96.5 ND
2 CT104 ,32 ND ND NEG 11.48199855 42.855 ND
3 CT105 ,32 ND ND NEG 2.636135549 ND ND
4 CT108 ,32 ND ND NEG 15.47424588 ND ND
5 CT114 ,32 ND ND NEG 3.039837995 173.5656 ND
6 CT115 ,32 ND ND NEG 8.717799266 1012 ND
7 CT116 ,32 ND ND NEG 14.84461638 ND ND
8 CT117 ,32 ND ND NEG 32.5336175 486 ND
9 CT118 ,32 ND ND NEG 7.909478419 51.8807 ND
10 CT 121 ,32 ND ND NEG 20.55072928 280.3494 ND
11 CT123 ,32 ND ND NEG 10.54691423 110.25 ND
12 CT134 ,32 ND ND NEG 0.749681205 2479.25 ND
13 CT140 ,32 ND ND NEG 5.858719662 ND ND
14 CT143 ,32 ND ND NEG ND ND ND
15 CT146 ,32 ND ND NEG ND 210.4035 ND
16 CT148 ,32 ND ND NEG 3.338386225 ND ND
17 CT149 ,32 ND ND NEG ND ND ND
18 CT154 ,32 ND ND NEG ND ND ND
19 CT157 ,32 ND ND NEG 6.119869271 371.481 ND
20 CT162 ,32 ND ND NEG ND ND ND
21 CT177 ,32 ND ND NEG 8.629805364 140.6814 43184.9312
22 CT179 ,32 ND ND NEG 11.41451537 ND 25399.2733
Samples with negative NAAT results were grouped in this table. HHV-6 DNA load in cervical smears as detected in qPCR assays is shown together with the HHV-6 DNA
load in total blood from the respective samples. Serological data for Chlamydia (Ctr) IgG, IgM and IgA has also been included. Ctr IgG values less than 32 (,32) indicate
IgG negative. ND, not detected; NEG, negative test result.
doi:10.1371/journal.pone.0061400.t002
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was observed in total leukocytes. The increase in the amount of
viral DNA in response to C. trachomatis infection was consistent in
all the 5 samples tested and was statistically significant (p,0.05).
Since not enough PBMCs from the five CiHHV-6 individuals
were available to perform control experiments in non-infected
total leukocytes and monocyte-derived macrophages, we repeated
these important control experiments with PBMCs from one
CiHHV-6 individual (Figure 1G) and thereby corroborated the
results shown in figure 1F.
Increased Viral DNA Replication is not Sufficient to
Produce Infectious Viral Particles
To test the long-term influence of C. trachomatis infection on
HHV-6 DNA replication, we repeated infections in HSB-ML cells
and kept the cells in culture till 35 days in presence of 1 mg/ml of
Doxycycline. The amount of viral DNA was increased up to 173-
fold within 35 days of first C. trachomatis infection (Figure 2A),
suggesting a strong induction of HHV-6 DNA replication under
these conditions. Southern hybridization of total DNA from these
cells verified the replication and presence of extra-chromosomal
HHV-6 DNA in 35 dpi HSB-ML cells, which represents the
activated HHV-6 DNA (Figure 2B). We repeated this experiment
in fresh PBMCs from one of the CiHHV-6 individuals and
observed appearance of full-length extra chromosomal HHV-6
DNA (Figure 2C) after 16 days of C. trachomatis infection. Further
long-term culture was not possible with isolated PBMCs because of
their limited life span in cell culture. We detected small viral DNA
(smaller than 48 kb) in mock-infected PBMCs without having any
full-length HHV-6 DNA. To differentiate extra-chromosomal
HHV-6 DNA between mock-infected and C. trachomatis-infected
PBMCs, we performed neutral-neutral 2D DNA electrophoresis
(Figure 2D), which differentiates DNA in 2 dimensions, by mass
and by conformation. We observed clear differences between both
the DNAs thus confirming our hypothesis that C. trachomatis
infection induces CiHHV-6 DNA replication and formation of
extra-chromosomal HHV-6 DNA. Hence our results show that C.
trachomatis infection promotes formation of extra-chromosomal
HHV-6 DNA and its replication in various cell types.
It has been previously shown that chemically induced latent
HHV-6 activation may or may not lead to formation of new viral
particles [3,26,27,28]. To test whether C. trachomatis-induced
HHV-6 DNA replication results in the formation of new infectious
viral particles, latently infected JL-LCL or HSB-ML cells were co-
cultivated with HSB-2 cells, which are permissive for the
production of HHV-6 viral particles. HSB-ML and JL-LCL were
infected with C. trachomatis (MOI 1–5) for 2–3 days, and then
grown in doxycycline (1 mg/ml) containing media for additional 7
days to avoid lysis of the cells due to chlamydial replication. These
cells were then co-cultured with fresh HSB-2 cells in order to allow
HHV-6 infection and propagation. After 2 weeks of co-culture,
2.56106 cells were collected and used for Gardella gel analysis (to
look for extra-chromosomal viral genomes). The co-culture
experiments were repeated at least 3 times. We detected low
amounts of both linear as well as circular HHV-6 DNA molecules
in all experiments (Figure 2E, S1). However, we could not detect
any infectious viral particles in the co-cultured cells by trans-
mission electron microscopy (data not shown). Interestingly, we
observed slow migrating, slightly higher molecular weight HHV-6
Table 3. Patients with no detectable HHV-6 in cervical smears.
Sample Ctr IgG Ctr IgM Ctr IgA Cervical virus load/103 cells
Cervical Ctr load/103
cells
Blood virus load/103
cells
1 CT100 ,32 ND ND ND (,5) 275809.309 7.99
2 CT124 128 ND ND ND (,5) 17020.3654 21.94766605
3 CT127 ,32+/2 ND ND ND (,5) 28133.5987 6.04619509
4 CT129 128 ND ND ND (,5) 20731.6709 6.483198133
5 CT133 64 80 ND ND (,5) 55086.4249 13.87471468
6 CT39 ,32 40 ND ND (,5) 137903.563 10.05636142
7 CT180 512 ND 40 ND (,5) 26844.5309 3.069298963
8 CT202 ,32 320 ND ND (,5) 29705.482 ND
9 CT219 ,32 320 40 ND (,5) 109665172 ND
10 CT194 ,32 160 ND ND (,5) 52664.978 ND
11 CT159 64 ND ND ND (,5) 2382.5124 ND
12 CT150 128 ND ND ND (,5) 65655.5437 ND
13 CT152 ,32 ND ND ND (,5) 1024506.99 ND
14 CT155 ,32+/2 160 20 ND (,5) 10184.9924 ND
15 CT179 ,32 ND ND ND (,5) 25399.2733 11.414
16 CT166 256 80 ND ND (,5) 39040.4813 8.052790338
17 CT172 128 ND ND ND (,5) 28609.4354 13.46552309
18 CT158 ,32+/2 ND ND ND (,5) 87336.546 1.606838633
19 CT144 128 40 ND ND (,5) 68366.6735 5.0838
20 CT142 32 ND ND ND (,5) 10114.0679 ND
21 CT220 512 ND ND ND (,5) 693.45099 1.193656128
HHV-6 DNA load in cervical smears as detected by qPCR assay is shown together with the HHV-6 DNA load in total blood from respective samples. Serological data for
Chlamydia (Ctr) IgG, IgM and IgA has also been included. Ctr IgG values less than 32 (,32) indicate IgG negative. ND, not detected.
doi:10.1371/journal.pone.0061400.t003
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extra-chromosomal DNA in co-cultured HSB-ML and JL-LCL
cells pointing to the possibility of additional confirmations for
HHV-6 DNA or presence of additional viral or non-viral
sequences than the known linear double stranded DNA
(Figure 2E, S1). In addition, we observed either nicked circular
or concatemeric HHV-6 DNA in all the co-cultured cells
(Figure 2E, S1), suggesting circularization of HHV-6 DNA. In
line with these observations, electron microscopic analysis of C.
Table 4. Co-existence of HHV-6 and Chlamydia in cervical smears.
Sample
Blood virus
load/103 cells
Cervical virus
load/103 cells
Cervical Ctr
load/103 cells Ctr IgG Ctr IgM Ctr IgA NAAT test
1 CT101 24.020291 67.4347 2387.141 128 ND ND POS
2 CT106 20.200325 112.0317 19837.0988 128 ND ND POS
3 CT107 37.025921 139.8426 61211.732 64 40 ND POS
4 CT109 13.846686 72.9132 29160.0152 64 ,20+/2 ND POS
5 CT110 61.280771 93.32419 1349.38604 128 ND ND POS
6 CT128 0.481486 52.1045 41414.9428 512 160 20 POS
7 CT184 ND 159.3826 2865.9608 128 ND ND POS
8 CT185 8.900063 164.0614 19937.801 256 ND ND POS
9 CT213 ND 279.5814 835.9657 128 ND ND POS
10 CT214 ND 40.6256 447.44 32 ND ND POS
11 CT208 ND 42.961 1099.5269 256 ND ND POS
12 CT204 ND 89.1299 21083.946 64 ND ND POS
13 CT191 ND 132.3496 22272.932 64 ND ND POS
14 CT187 ND 130.9461 1291.9818 32 ND ND POS
15 CT203 ND 30.4866 143097.31 ,32+/2 ND ND POS
16 CT210 89.257277 42.15 3811.1949 64 ND ND POS
17 CT153 ND 15.12106 127449 ,32 160 ND POS
18 CT163 ND 49.8583 43224.5877 64 ND ND POS
19 CT174 7.129155 32.4432 8443.53909 64 ND ND NEG
20 CT178 13.465523 52.4139 4763.27749 32 160 ND POS
21 CT176 3.801527 57.9939 22412.0638 ,32+/2 20 ND NEG
22 CT175 10.633452 25.0302 3125.70194 ,32+/2 ND ND POS
23 CT206 ND 203.0779 6519.2924 – – – POS
Samples with detectable HHV-6 DNA as well as chlamydial (Ctr) DNA in cervical smears were grouped in this table. HHV-6 DNA load in cervical smears and in total blood
from the respective samples are shown together with serological data for Chlamydia IgG, IgM and IgA. Ctr IgG values less than 32 (,32) indicate IgG negative. ND, not
detected; POS, positive test result; NEG, negative test result.
doi:10.1371/journal.pone.0061400.t004
Table 5. Two-way Chi-square test to study the association between Chlamydia and HHV-6 load in cervical smear of all patients.
Chlamydial load** HHV-6 viral load (per 10
3 cells)*
Group 1 (,5) Group 2 (5–100)
Group 3 (100–
200) Group 4 (.200) Total no. of samples
No. of samples within group A 15 5 2 0 22
Rel. frequency within group A 68,2% 22,7% 9,1% 0,0% 100,0%
No. of samples within group B 6 10 5 2 23
Rel. frequency within group B 26,1% 43,5% 21,7% 8,7% 100,0%
No. of samples within group C 17 3 4 4 28
Rel. frequency within group C 60,7% 10,7% 14,3% 14,3% 100,0%
Total no. of samples 38 18 11 6 73
Rel. frequency within all groups 52,1% 24,7% 15,1% 8,2% 100,0%
*Samples have been arbitrarily divided into 4 sub groups (group 1, 2, 3 and 4) depending on the HHV-6 viral load. Respective HHV-6 DNA load is mentioned within
brackets.
**Similarly, all the samples have been arbitrarily divided into 3 sub groups (group A, B and C) depending on the chlamydial (Ctr) DNA load. Group A: more than 25,000
copies of Ctr/1000 cells, Group B: between 100–25,000 copies/1000 cells, Group C: Below 100 copies of Ctr (not detectable)/1000 cells.
doi:10.1371/journal.pone.0061400.t005
Chlamydia Induces HHV-6 DNA Replication
PLOS ONE | www.plosone.org 9 April 2013 | Volume 8 | Issue 4 | e61400
trachomatis-infected HSB-ML, JL-LCL and PL-LCL cells could not
show presence of any viral particles in these cells. Only condensed
particle like DNA structures were detected in their nuclei
(Figure 2F). Thus, our data shows that C. trachomatis infection
reactivates replication of HHV-6 in CiHHV-6 cells without
leading to infectious virus particle formation.
qPCR Assays for Quantification of HHV-6 and C.
trachomatis DNA
Our previous [23] as well as the present study using cell culture
models indicated that C. trachomatis infection has an effect on active
as well as latent HHV-6 infection. To investigate the nature of C.
trachomatis and HHV-6 co-infection in a clinically relevant
situation, we established methods to detect these microbes in
patient samples. Latent HHV-6 DNA can be detected in various
body parts [29,30] including cervical epithelial tissues [31,32]
where they influence human papillomavirus (HPV) gene regula-
tion [2]. C. trachomatis is a mucosal pathogen and its DNA can be
detected in various grades of cervical neoplasia as well as in
asymptomatic patients [33,34]. Hence, the possibility of an
interaction between Chlamydia and HHV-6 in cervical epithelial
cells is plausible.
We therefore studied cervical swabs from 73 female patients and
determined C. trachomatis load and HHV-6 viral load. As the
number of cervical epithelial cells in such samples can be quite
low, we developed a highly efficient SYBR green- based
quantitative real time PCR (qPCR) assay to detect low amounts
of microbial DNA in small samples.
For preparation of standard curves, we cloned a PCR-amplified
full-length HHV-6A (U1102 strain), HHV-6B (Z29) U94
(1473 bp) ORF and a 136 bp fragment of C. trachomatis type III
secretion chaperon LcrH/SycD into TOPO pCR 2.1 (Life
Technologies, Germany) vector backbone. Primers for HHV-6
U94 ORF, one of the well-studied transcripts essential for HHV-6
latency, were selected for qPCR and standard curve analysis
[23,35]. As the type III secretion chaperon of C. trachomatis is
essential for chlamydial survival and infection, it was selected for
qPCR as well as standard curve analysis. For normalization of
microbial DNA to cellular DNA, we selected PI15 ORF
(NM_015886), a gene that exists as a single copy per haploid
genome (or 2 copies per human cell) and cloned the full-length
PI15 (777 bp) into the same vector backbone. The recombinant
plasmid standards were diluted serially 10-fold starting from 1
plasmid copy per ml to 106 copies per ml. The standards were then
amplified in triplicates (1–106 copies per well) in a single run and
the data collected were used to generate a linear-log regression
plot. To evaluate inter- and intra-experimental variation, we
repeated these tests at least 5 times and for 5 different time points
and calculated the co-efficient of variation (CV) (Table S2). For all
the 3 standards, mean Ct values from triplicates were plotted
against plasmid copy number per reaction, which resulted in
a linear graph (Figure 3A–C). The calculated detection limit was 5
copies for HHV-6, 100 copies for C. trachomatis and 100 copies for
PI15 per reaction with a CV value of less than 5%. Detection of
HHV-6, C. trachomatis and PI15 was highly efficient over a wide
range (5 to 10,000 copies per reaction). Ten randomly selected
PCR products from each PCR were verified by sequencing.
HHV-6 and C. trachomatis Load in Cervical Swabs and
Total Blood DNA
The established qPCR assays were utilized to detect HHV-6
and chlamydial DNA in cervical swabs as well as in DNA of total
blood of patients. Based on qPCR results, the distribution pattern
of different patient samples is shown in Table 1. A scatter plot was
generated to visualize the correlation of HHV-6 and chlamydial
load in cervical swab samples (only samples, which were either
positive for HHV-6 or Chlamydia or for both (n= 65) were
included) (Figure 3D).
Interestingly, we observed 2 clearly different groups of patients
in terms of the viral and chlamydial load in their cervical swabs.
The C. trachomatis negative group (n= 22) comprised patients with
symptoms suggestive of genital infection or with partners having C.
trachomatis infection, but negative serology as well as negative C.
trachomatis NAAT test (Table 1, 2). We could detect chlamydial
DNA in cervical samples from two of these patients, whereas 20
were negative also by our qPCR assay. Interestingly, 18 out of
these 22 patients had high viral load either in blood or in cervical
swabs or both. 12 out of these 18 HHV-6 positive patients had
detectable HHV-6 in cervical swab samples and all of them had
higher viral load in cervical swabs than their blood.
Another group (n= 21) of patients were positive for C. trachomatis
DNA but no HHV-6 DNA was detectable (Table 1, 3) in their
respective cervical swabs. 18 patients had also serological evidence
of C. trachomatis infection: 8 had IgM, 16 had IgG and four had
both IgG and IgM antibody. In 13 of the 21 patients HHV-6
DNA was detected in the blood.
We detected both HHV-6 and C. trachomatis DNA in cervical
swabs of 23 patients (Table 1, 4). In 12 of these 23 patients, higher
levels of viral DNA could be detected in cervical swab samples
than in the blood. In the blood of the remaining 11 patients,
HHV-6 DNA was not measurable. All these patients had
detectable chlamydial DNA in the same cervical sample. 20 of
these patients (90.9%) were positive for C. trachomatis IgG antibody
indicating previous exposure to C. trachomatis or long-term
infection, and 6 of them had also IgM antibody. Interestingly,
none of these patients had high chlamydial load in their cervical
swabs. In conclusion, our qPCR assay detected high HHV-6 load
in cervical swab samples from patients with C. trachomatis infection
supporting an interaction between these two microbes also in
patients.
Discussion
C. trachomatis is a sexually transmitted mucosal pathogen and
very frequently detected in cervical epithelial cells of infected
patients [36,37]. Yet, role of chlamydial infection in these patients
is not well understood. In our previous report, we showed that
active HHV-6 infection induces chlamydial persistence in HeLa
cells. On the other hand, Chlamydia infection favors HHV-6
infection and survival. As most humans acquire HHV-6 infection
early in life and C. trachomatis infection later, we addressed the
question whether C. trachomatis infection can activate latent HHV-
6 infection. Several chemical stimuli have been shown to activate
viral replication in CiHHV-6 cell lines leading to formation of
infectious viral particles [3]. Therefore, we tested 3 CiHHV-6 cell
lines as well as PBMCs from 5 individuals having CiHHV-6 for
their ability to induce viral replication after C. trachomatis infection.
We observed an increase in the amount of viral DNA in all the cell
types within 5–9 days after C. trachomatis infection. This increase in
viral DNA was comparable to that induced by known chemical
inducers like TSA [3]. However, unlike reactivation with chemical
stimuli, long-term co-culture experiments did not result in
infectious virus production. It is currently unclear, why formation
of infectious viral particles was not detected after long-term
culture. While chemical inducers are easily accessible for every cell
in a particular experiment, Chlamydia infection is highly asynchro-
nous in cultured suspension cells. Under most successful infection
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conditions, only 40–70% of the cells can be infected with C.
trachomatis. Also, C. trachomatis has a highly lytic life cycle in
cultured cells, which prevents development of long term Chlamydia
infection in vitro. Thus, it is possible that any signal for HHV-6
activation resulting from Chlamydia infection is only available for
limited time in vitro, preventing complete activation of HHV-6
DNA replication in our co-culture experiments.
Activation of HHV-6 leading to extra-chromosomal HHV-6
DNA formation might be the initial stage for virus activation. We
observed formation of extra-chromosomal linear HHV-6 DNA in
all the CiHHV-6 cell lines after C. trachomatis infection as well as in
total PBMCs from one of the CiHHV-6 individuals. We detected
HHV-6 DNA smaller than 48–kb in length in mock infected
PBMCs from the CiHHV-6 individual (Figure 2C, 2D), which
might represent spontaneously activated and incomplete HHV-6
DNA in these cells or can originate from community-acquired
HHV-6 strains. In addition, we detected slowly migrating HHV-6
DNA in C. trachomatis infected CiHHV-6 cells co-cultured with
permissive HSB-2 cells (Figure 2E, S1), which might represent
either nicked circular or concatemeric HHV-6 DNA. In both
cases, generation of extra-chromosomal circular HHV-6 DNA can
be postulated as reason for this observation. Circular HHV-6
DNA is rarely detected [1,2] in some of the cell lines infected with
HHV-6, but the exact role of such circular viral DNA is unclear.
Circular viral genome is postulated to be the start of replication for
different herpes viruses, which can form precursors for linear viral
DNA by rolling circle amplification mechanism [38,39,40,41,42].
Thus our results suggest possible viral activation in these cells in
response to C. trachomatis infection, which leads to formation of
extra-chromosomal HHV-6 DNA.
To check whether HHV-6 activation is restricted to certain cell
types, we infected total blood leukocytes and monocyte-derived
macrophages with C. trachomatis. Although we observed increase in
the amount of viral DNA in both the cell types, HHV-6 DNA
replication was more efficient in human macrophages. This may
be due to the fact that macrophages are more susceptible to C.
trachomatis infection than in leukocytes [23] thus leading to a better
induction signal for HHV-6 DNA replication. It will be interesting
in future to see the effect of increased viral DNA accumulation on
transcription and translation profile of HHV-6 and its conse-
quence on chlamydial growth.
To obtain evidence for a role of C. trachomatis and HHV-6
infections in clinical settings, we analyzed cervical swabs taken
from patients with suspected C. trachomatis infection for the
presence of HHV-6 and chlamydial DNA by qPCR. Results
obtained with our established C. trachomatis qPCR assay correlated
very well with those obtained using a commercial NAAT test with
91.7% of the specimens having similar results by both detection
methods. The few discrepant results may be due to the sample
collection as separate cervical swabs collected in different media
were used for NAAT and the qPCR assay (see Material and
Methods), or different analytical sensitivities (rRNA detection vs.
DNA detection). Besides being qualitative, our qPCR assay could
also quantitate the C. trachomatis load. We detected HHV-6 DNA
in 48% of the tested samples. Although the amount of HHV-6
DNA in cervical swabs of Chlamydia-infected patients is compar-
atively high, HHV-6 or other HHVs have been frequently
detected in cervical swabs earlier [17,43,44,45]. We also detected
HHV-6 DNA in blood cells of 59% of the patients. Although
HHV-6 DNA has previously been detected in PBMCs of 40–90%
of healthy individuals [46], the viral DNA copy numbers have not
been determined in these studies. Thus, the detection of 103–104
copies of HHV-6 DNA per 106 cells in total blood of C. trachomatis-
infected patients points to a high probability of viral activation in
all these patients.
We observed high viral loads either in total blood or cervical
swabs from 55 patients. Interestingly, 81.8% of the patients in the
C. trachomatis negative group had activated HHV-6 in their blood.
HHV-6 levels in the whole blood of healthy individuals range
between 5–10 copies per ml of blood [30]. Similarly, in CiHHV-6
patients, HHV-6 DNA levels exceed 5.5 log10 copies/ml [4].
HHV-6 DNA load in total blood, which lies in between these two
extremes, indicates an activated state of the virus. Remarkably,
66.7% of the C. trachomatis negative patients with activated HHV-6
in their blood also had high viral titers in cervical epithelial cells
ranging up to 5–6 log10 per 106 cells in 10 of the samples (Table 2).
Cervical epithelial cells are not known to be permissive for
productive HHV-6 infection. High viral DNA in these cells could
also come from blood cells derived from blood vessels associated
with cervical tissue. But this assumption may not be valid as the
viral titer was comparatively low in whole blood samples in the
respective patients. Thus, we assume that high viral titer in cervical
swabs could originate from localized activation of viral replication
in cervical epithelial cells or in blood cells that enrich cervical
epithelium and thus come in contact with cervical epithelial cells.
We observed coexistence of HHV-6 and Chlamydia in 23
samples (Table 4). Viral load was high in all these samples
indicating HHV-6 activation. Similar to the previous observation,
the blood HHV-6 load was comparatively low or negative in all
these 23 patients in comparison to the viral load in their cervix.
This could again be due to localized activation of HHV-6 in
cervical epithelial cells in the presence of Chlamydia infection.
Presence of chlamydial IgG antibody in 21 of these patients
indicates the presence of chronic or long-term C. trachomatis
infection, which supports our results from cell culture based HHV-
6 reactivation studies.
For a better understanding of our study results, we divided the
patients into 4 subgroups according to the viral load (group 1, 2, 3
and 4) and according to the chlamydial load into 3 subgroups
(group A, B and C) (Figure 3D). Using the Kruskal-Wallis test, we
observed a negative correlation between viral and bacterial load
(Table S3). However, due to high degree of standard deviation,
particularly within the samples with high chlamydial DNA load
the correlation did not reach statistical significance. Low
chlamydial DNA load has been detected in incident C. trachomatis
infections in comparison to prevalent infections [36]. This could
indicate that an active chlamydial infection might be associated
with high chlamydial load whereas persistent or recovered
infections would have lower organism loads. Thus, we excluded
the samples (n = 22) with high chlamydial load (group A) and
analyzed the patients with no C. trachomatis and low to moderate C.
trachomatis load (group B and C). A statistically significant
association between chlamydial and viral load was observed in
these subgroups (Table S4). A two-way chi-square test within these
subgroups also showed statistically significant association (Table
S5).
In contrast to Kruskal-Wallis ANOVA test involving total
samples, a two-way chi-square test revealed a statistically signif-
icant negative association (p,0.05) between viral and bacterial
load (Table 5). Samples with high viral titer in cervix had a low
chlamydial load whereas samples with low viral titer in cervix had
a high chlamydial load (Figure 3D).
We observed 16 cases where both cervical swab as well as total
blood was negative for HHV-6 DNA. In comparison, 22 samples
had high viral load in blood whereas no HHV-6 was detected in
their respective cervical swabs. As we cannot confirm the source of
viral activation in whole blood of these 22 patients, we analyzed
Chlamydia Induces HHV-6 DNA Replication
PLOS ONE | www.plosone.org 11 April 2013 | Volume 8 | Issue 4 | e61400
the rest of the 35 cases where high HHV-6 DNA titer was
observed in cervical swabs (n = 34) in comparison to their whole
blood counterpart by a binomial test (Table S6). We observed
a statistically significant preference for viral activation in cervical
epithelial tissues compared to whole blood, which can be
attributed to co-infection of cervical tissue with other pathogens
including C. trachomatis.
Our qPCR results show strong correlation between HHV-6 and
C. trachomatis infection in these patients. However, currently the
role of other pathogens like Herpes simplex virus 1 and 2 (HSV1/
2) [47] or Neisseria gonorrhoeae [37], which are also regularly
detected in cervical epithelial cells, remains elusive. More
elaborate studies are required to understand the exact mechanism
behind such co-infections and their effect on disease progression.
Although HHV-6 is very frequently detected in various grades of
cervical lesions, a role of HHV-6 in cervical cancer is still
debatable. Because of lack of any molecular mechanism to
associate HHV-6 together with other pathogens to cervical cancer,
HHV-6 has been so far regarded as a bystander [48] in the
oncogenesis of cervical cancer. At the same time, several studies
have pointed out a strong role of HHV-6 in cervical pathogenesis
[17,31,49,50]. To the best of our knowledge, no in depth study has
been carried out so far to look for possible mechanism and role of
HHV-6 and Chlamydia in cervical diseases. Our study for the first
time links Chlamydia infection to HHV-6 pathogenesis in cervical
epithelial cells. More detailed study in this regard is necessary to
understand the consequences of such interactions in the context of
disease development.
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Figure S1 Gardella gel analysis and subsequent southern
hybridization showing extra-chromosomal HHV-6 DNA after C.
trachomatis infection. HSB-ML cells were infected with C. trachomatis
(MOI 5) for 2 days after which cells were washed thoroughly and
grown in presence of fresh media with 1 mg/ml of doxycycline for
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ethidium bromide and afterwards transferred to a nylon mem-
brane. HHV-6-infected HSB-2 for productive virus infection
(HSB-2+HHV-6), C. trachomatis elementary bodies (purified Ctr
EB) and C. trachomatis-infected HSB-ML cells, which were
subsequently not co-cultured with HSB-2 cells (HSB-ML+Ctr)
were loaded as controls. Nylon membrane was hybridized with
HHV-6-specific probe. Extra-chromosomal linear HHV-6 DNA
and possible nicked circular viral DNA are marked.
(TIF)
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cloning of plasmids for standard curve generation.
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Table S2 Intra- and inter-assay variability for qPCR assay. Ct,
cycle threshold; SD, standard deviation; CV, coefficient of
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Table S3 Kruskal-Wallis test to demonstrate the association
between Chlamydia and HHV-6 load in cervical smear of all
patients. Samples have been arbitrarily divided into 4 sub groups
(group 1, 2, 3 and 4) depending on the HHV-6 viral load.
Respective HHV-6 DNA load is mentioned within brackets. SD,
standard deviation.
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Table S4 Kruskal-Wallis test to demonstrate the association
between Chlamydia and HHV-6 load in cervical smear of patients
with moderate to low chlamydial load. Group B: Chlamydial
DNA load between 100–25000 chlamydial genome copies/1000
cells; Group C: Chlamydial DNA load below 100 genome copies
(not detectable)/1000 cells. *Samples have been arbitrarily divided
into 4 sub groups (group 1, 2, 3 and 4) depending on the HHV-6
viral load. Respective HHV-6 DNA load is mentioned within
brackets. SD, standard deviation. Significance = 0.048.
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Table S5 Two-way Chi-square test to demonstrate the associ-
ation between Chlamydia and HHV-6 load in cervical smear of
patients having moderate to low chlamydial load. *Samples have
been arbitrarily divided into 4 sub groups (group 1, 2, 3 and 4)
depending on the HHV-6 viral load. Respective HHV-6 DNA
load is mentioned within brackets. Similarly, all the samples have
been arbitrarily divided into 3 sub groups (group A, B and C)
depending on the chlamydial DNA load. **Group B: between
100–25000 DNA chlamydial genome copies/1000 cells; Group C:
Below 100 chlamydial genome copies (not detectable)/1000 cells.
Significance = 0.024.
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Table S6 Binomial test showing higher preference of HHV-6
activation in cervical epithelial cells than in the whole blood
counterpart. Group 1, samples where HHV-6 copy number in
cervical smear is more than in total blood. Group 2, samples where
HHV-6 copy number in cervical smear is less than in total blood.
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